Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winston Tan

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate CancerLawrence Fong, Michael J Morris, Oliver Sartor, et al.
Clinical Pharmacology and Therapeutics|March 15, 2022
Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate CancerSisi Qin, Huanyao Gao, Wootae Kim, et al.
Haematologica|December 4, 2025
Inherited DNA repair variants are associated with clonal hematopoiesis and cardiovascular risk in men with metastatic prostate cancerOlisaemeka Ogbue, Yael Kusne, Osama Mosalem, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2021
Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancerHui-Ming Lin, Kevin Huynh, Manish Kohli, et al.
Molecular Cancer Research : MCR|September 22, 2022
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone TreatmentHugues Sicotte, Krishna R Kalari, Sisi Qin, et al.
European Urology|August 18, 2014
Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancerXiaoyi Huang, Tiezheng Yuan, Meihua Liang, et al.
Journal of Clinical Medicine|June 24, 2022
Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast CancerKrithika Krishnarao, Katelyn A Bruno, Damian N Di Florio, et al.
Frontiers in Oncology|September 10, 2021
Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate CancerXiaoxi Dong, Tiantian Zheng, Minhua Zhang, et al.
European Urology|June 4, 2020
Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate CancerHeidi Fettke, Edmond M Kwan, Maria M Docanto, et al.
BMJ Open|April 17, 2016
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancerSteven N Hart, Marissa S Ellingson, Kim Schahl, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate CancerLawrence Fong, Michael J Morris, Oliver Sartor, et al.
Clinical Pharmacology and Therapeutics|March 15, 2022
Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate CancerSisi Qin, Huanyao Gao, Wootae Kim, et al.
Haematologica|December 4, 2025
Inherited DNA repair variants are associated with clonal hematopoiesis and cardiovascular risk in men with metastatic prostate cancerOlisaemeka Ogbue, Yael Kusne, Osama Mosalem, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2021
Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancerHui-Ming Lin, Kevin Huynh, Manish Kohli, et al.
Molecular Cancer Research : MCR|September 22, 2022
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone TreatmentHugues Sicotte, Krishna R Kalari, Sisi Qin, et al.
European Urology|August 18, 2014
Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancerXiaoyi Huang, Tiezheng Yuan, Meihua Liang, et al.
Journal of Clinical Medicine|June 24, 2022
Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast CancerKrithika Krishnarao, Katelyn A Bruno, Damian N Di Florio, et al.
Frontiers in Oncology|September 10, 2021
Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate CancerXiaoxi Dong, Tiantian Zheng, Minhua Zhang, et al.
European Urology|June 4, 2020
Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate CancerHeidi Fettke, Edmond M Kwan, Maria M Docanto, et al.
BMJ Open|April 17, 2016
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancerSteven N Hart, Marissa S Ellingson, Kim Schahl, et al.
Pageof 9